Hemanth Kumar Manikyam: The Complex Immunology Behind Platelet Destruction in ITP
Hemanth Kumar Manikyam, Vice President of Research And Development at Botanic Healthcare, Visiting Professor at Chalapathi Institute of Pharmaceutical Sciences, Lam, shared a post on LinkedIn:
“Immune thrombocytopenia (ITP): A B-cell-macrophage immune network disorder?
Insights from Mother INP 11-Layer Analysis.
Immune Thrombocytopenia (ITP) is commonly described as a low platelet disorder.
However, our Mother INP 11-Layer analysis suggests that ITP is fundamentally an immune network disease involving autoantibody production, immune tolerance failure, chronic inflammation, excessive macrophage activity, and impaired platelet regeneration.
The primary failure nodes identified include:
- B-cell hyperactivation
- Autoantibody production against platelet glycoproteins
- Regulatory T-cell dysfunction
- Splenic macrophage overactivity
- NF-κB activation
- TNF-α and IL-6 elevation
- Megakaryocyte dysfunction
KEGG pathway prioritization highlighted B-cell receptor signaling, Fcγ receptor signaling, JAK-STAT, NF-κB, PI3K-AKT, complement activation, and cytokine-mediated immune pathways as key drivers of disease progression.
Using the Mother INP Engine, several phytochemicals emerged as high-priority restoration molecules.
Curcumin demonstrated broad immune-modulating effects through NF-κB, TNF-α, and IL-6 regulation.
Withanolides from Ashwagandha showed potential to support immune homeostasis and reduce inflammatory burden.
Quercetin demonstrated activity across cytokine signaling, oxidative stress reduction, and immune regulation pathways.
EGCG exhibited interactions with JAK-STAT and inflammatory signaling networks while supporting antioxidant defense systems.
The highest-priority recovery nodes identified were:
- Immune tolerance restoration
- Reduction of autoantibody formation
- Regulation of B-cell activity
- Suppression of excessive macrophage-mediated platelet destruction
- NF-κB modulation
- Cytokine balance restoration
- Support of megakaryocyte maturation
Network propagation analysis suggests that platelet destruction is not an isolated event but a downstream consequence of a larger immune signaling imbalance involving B cells, T cells, macrophages, cytokines, and inflammatory mediators.
The most promising phytochemical restoration cluster identified through the Mother INP framework was:
Epicatechin plus Curcumin plus Withanolides plus Quercetin plus EGCG working across multiple immune and inflammatory nodes simultaneously.
Mother INP Conclusion:
ITP is not simply a platelet deficiency disorder.
It is a systems-level immune dysregulation syndrome driven by immune tolerance failure, autoantibody production, inflammatory signaling, and hematological imbalance.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 11:48A Century of VWD: Redefining Its Role Beyond Hemostasis
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026